# Anthos Therapeutics, Inc.

Organization · id `cardio:org-anthos-therapeutics-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Anthos+Therapeutics%2C+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Anthos Therapeutics, Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (`cardio:ct-nct04755283`)
- Sponsors: A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (`cardio:ct-nct05171049`)
- Sponsors: A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (`cardio:ct-nct05171075`)
- Sponsors: Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (`cardio:ct-nct05712200`)

## Provenance

Content hash: f8f73b54c96f33745384bd63044b65cceb3bf64422aa968f4e981540b658c1e4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
